What is Ayvakit?: A Guide to the Targeted Therapy
•
3 min read
Ayvakit (avapritinib) is a prescription medicine, first approved by the FDA in 2020 for certain gastrointestinal stromal tumors, that functions as a targeted therapy. This innovative drug is designed to attack the specific genetic mutations that drive the growth of certain cancers and blood disorders, offering a more precise treatment approach than traditional chemotherapy.
